CN1348498A - 新的核酸转移试剂、含有它们的组合物及其应用 - Google Patents

新的核酸转移试剂、含有它们的组合物及其应用 Download PDF

Info

Publication number
CN1348498A
CN1348498A CN99813646A CN99813646A CN1348498A CN 1348498 A CN1348498 A CN 1348498A CN 99813646 A CN99813646 A CN 99813646A CN 99813646 A CN99813646 A CN 99813646A CN 1348498 A CN1348498 A CN 1348498A
Authority
CN
China
Prior art keywords
nucleic acid
transfering reagent
amino
composition
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99813646A
Other languages
English (en)
Chinese (zh)
Inventor
J·赫斯科维丝
H·霍夫兰德
C·杰科宾
D·谢尔曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9815309A external-priority patent/FR2786700B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of CN1348498A publication Critical patent/CN1348498A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CN99813646A 1998-12-03 1999-12-02 新的核酸转移试剂、含有它们的组合物及其应用 Pending CN1348498A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR98/15309 1998-12-03
FR9815309A FR2786700B1 (fr) 1998-12-03 1998-12-03 Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs utilisations
US11718499P 1999-01-26 1999-01-26
US60/117,184 1999-01-26

Publications (1)

Publication Number Publication Date
CN1348498A true CN1348498A (zh) 2002-05-08

Family

ID=26234691

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99813646A Pending CN1348498A (zh) 1998-12-03 1999-12-02 新的核酸转移试剂、含有它们的组合物及其应用

Country Status (13)

Country Link
EP (1) EP1137793A2 (cs)
JP (1) JP2002531468A (cs)
KR (1) KR20010101116A (cs)
CN (1) CN1348498A (cs)
AU (1) AU772033B2 (cs)
BR (1) BR9915897A (cs)
CA (1) CA2353576A1 (cs)
CZ (1) CZ20011909A3 (cs)
HU (1) HUP0200345A3 (cs)
IL (1) IL142704A0 (cs)
NO (1) NO20012684L (cs)
PL (1) PL348513A1 (cs)
WO (1) WO2000032803A2 (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103820320A (zh) * 2013-06-25 2014-05-28 宁波有成生物医药科技有限公司 一种非冻型rna保护液

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805271B1 (fr) * 2000-02-18 2002-04-26 Aventis Pharma Sa Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
JP2005080598A (ja) * 2003-09-10 2005-03-31 Japan Science & Technology Agency β−１，３−グルカン誘導体を用いるプラスミドＤＮＡの導入法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4690596A (en) * 1994-12-30 1996-07-24 Chiron Viagene, Inc. Nucleic acid condensing agents with reduced immunogenicity
FR2730637B1 (fr) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103820320A (zh) * 2013-06-25 2014-05-28 宁波有成生物医药科技有限公司 一种非冻型rna保护液

Also Published As

Publication number Publication date
HUP0200345A2 (hu) 2002-05-29
IL142704A0 (en) 2002-03-10
AU1564600A (en) 2000-06-19
NO20012684L (no) 2001-07-30
HUP0200345A3 (en) 2003-12-29
JP2002531468A (ja) 2002-09-24
AU772033B2 (en) 2004-04-08
CZ20011909A3 (cs) 2001-09-12
WO2000032803A2 (fr) 2000-06-08
PL348513A1 (en) 2002-06-03
CA2353576A1 (fr) 2000-06-08
EP1137793A2 (fr) 2001-10-04
KR20010101116A (ko) 2001-11-14
BR9915897A (pt) 2001-08-21
NO20012684D0 (no) 2001-05-31
WO2000032803A3 (fr) 2000-10-12

Similar Documents

Publication Publication Date Title
CN115484932B (zh) 用于靶向rna递送的组合物和方法
AU2025205468A1 (en) Messenger rna vaccines and uses thereof
EP0968227B1 (en) Dimeric cationic lipids on dicystine basis
US12290567B2 (en) Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates
US6743781B2 (en) Glycerolipid compounds useful for the transfer of an active substance into a target cell
US5877220A (en) Amide-based oligomeric cationic lipids
JP5087924B2 (ja) ガラクトース誘導体、薬物担体及び医薬組成物
CN106795096A (zh) 用于递送核酸的新型脂质和脂质纳米颗粒制剂
CN107406396A (zh) 阳离子性脂质
CA2227373A1 (en) Novel amide-based cationic lipids
CN1211989A (zh) 用于传递核酸的组合物和方法
US20250381139A1 (en) Multi-tail type ionizable lipid, preparation method therefor and use thereof
EP4110296A1 (en) Improved processes of preparing mrna-loaded lipid nanoparticles
IL323798A (en) Reconstituted dry powder formulations and methods of use thereof
CN1348498A (zh) 新的核酸转移试剂、含有它们的组合物及其应用
CN1259134A (zh) 新型的核酸阳离子转染剂
CN1452617A (zh) 酸敏感化合物、其制备方法和用途
CN1289371A (zh) 对还原条件敏感的转染化合物,含有它们的药物组合物及其应用
CN117813383B (zh) 用于抑制CIDEB基因表达的siRNA、药物及其应用
TW202604542A (zh) 含有苯環結構的長效脾靶向陽離子脂質化合物、包含其的組合物及用途
JP4276439B2 (ja) ポリチオ尿素の脂質誘導体
CN120905313A (zh) 一种核酸分子递送载体及其冻干制剂制备方法和用途
CN118076360A (zh) 用于靶向rna递送的组合物和方法
US20250312288A1 (en) Lipids and lipid nanoparticle formulations
CN121013730A (zh) 脂质颗粒

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication